KLF13
Krueppel-like factor 13
Also known as: BTEB3, FKLF-2, KLF13_HUMAN, NSLP1, RFLAT-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2Y9
- Gene
- KLF13
- Ensembl
- ENSG00000169926
- Chromosome
- 15
- Canonical length
- 288 aa
- Protein class
- Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
KLF13 belongs to a family of transcription factors that contain 3 classical zinc finger DNA-binding domains consisting of a zinc atom tetrahedrally coordinated by 2 cysteines and 2 histidines (C2H2 motif). These transcription factors bind to GC-rich sequences and related GT and CACCC boxes (Scohy et al., 2000 [PubMed 11087666]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
288 residues, UniProt reviewed canonical sequence.
>Q9Y2Y9|KLF13
1 MAAAAYVDHF AAECLVSMSS RAVVHGPREG PESRPEGAAV AATPTLPRVE ERRDGKDSAS
61 LFVVARILAD LNQQAPAPAP AERREGAAAR KARTPCRLPP PAPEPTSPGA EGAAAAPPSP
121 AWSEPEPEAG LEPEREPGPA GSGEPGLRQR VRRGRSRADL ESPQRKHKCH YAGCEKVYGK
181 SSHLKAHLRT HTGERPFACS WQDCNKKFAR SDELARHYRT HTGEKKFSCP ICEKRFMRSD
241 HLTKHARRHA NFHPGMLQRR GGGSRTGSLS DYSRSDASSP TISPASSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLF13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 59 nTPM
- cerebellum: 50 nTPM
- thymus: 45 nTPM
- pancreas: 42 nTPM
- skeletal muscle: 37 nTPM
- skin: 32 nTPM
Single-cell type
- proximal tubule cells: 96 nCPM
- oligodendrocytes: 76 nCPM
- renal collecting duct intercalated cells: 67 nCPM
- renal connecting tubule cells: 60 nCPM
- renal collecting duct principal cells: 55 nCPM
- loop of henle epithelial cells: 47 nCPM
Immune cell
- memory B-cell: 27 nTPM
- naive B-cell: 24 nTPM
- T-reg: 21 nTPM
- naive CD8 T-cell: 21 nTPM
- plasmacytoid DC: 21 nTPM
- MAIT T-cell: 14 nTPM
Brain region
- white matter: 96 nTPM
- cerebellum: 89 nTPM
- thalamus: 86 nTPM
- cerebral cortex: 82 nTPM
- hippocampal formation: 69 nTPM
- medulla oblongata: 67 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0.4
- gnomAD missense Z
- 2.02
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cell population proliferation
- negative regulation of erythrocyte differentiation
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLF13 as an antibody target. Whether an autoantibody or antibody against KLF13 could matter depends on whether native KLF13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLF13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KLF13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...